Eko Analysis Software vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Devices
VS
by Medicalgorithmics

AI Verdict

Eko Analysis Software is designed for clinicians using Eko's digital stethoscopes, offering AI-powered detection of heart murmurs and atrial fibrillation primarily through auscultation and integrated ECG. DeepRhythmAI, conversely, is a device-agnostic, cloud-based AI algorithm focused on comprehensive cardiac arrhythmia detection and classification solely from ECG data. While both leverage AI for cardiac rhythm analysis, Eko integrates hardware for broader cardiovascular screening, whereas DeepRhythmAI provides a more specialized and extensive software solution for ECG-based arrhythmia diagnostics.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you are a clinician seeking an integrated solution for real-time, point-of-care cardiovascular screening and remote monitoring. It is ideal for primary care, emergency medicine, or telehealth, allowing you to combine digital auscultation with AI-powered detection of heart murmurs and AFib directly during patient encounters and save recordings for later review.

View Eko Analysis Software →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered analysis and classification of large volumes of existing ECG data. This cloud-based algorithm is best suited for cardiology practices or health systems that require a device-agnostic solution to streamline ECG reporting, significantly reduce missed arrhythmia diagnoses, and improve overall workflow efficiency.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software DeepRhythmAI
Pricing Freemium with subscription for full features Contact vendor for pricing information
Deployment Cloud-based Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software (Tool A) integrates with Eko's digital stethoscopes and a mobile app, offering a direct and intuitive user experience at the point of care for clinicians. DeepRhythmAI (Tool B) is a cloud-based algorithm with an API, designed for integration into third-party software and devices, and explicitly states it 'doesn't have User Interface', making it less directly usable by an end-user clinician without another system.

Clinical Value

DeepRhythmAI

DeepRhythmAI (Tool B) boasts impressive, quantified clinical outcomes, claiming to reduce missed diagnoses by 14x to 114x and increase workflow efficiency by up to 65%. It is trained on an exceptionally large dataset of over 250 billion annotated heartbeats. While Eko Analysis Software (Tool A) provides valuable FDA-cleared detection for murmurs and AFib, Tool B's specific metrics and extensive training data suggest a potentially higher and more proven clinical impact in its specialized domain of arrhythmia detection and classification.

Pricing & Value

Eko Analysis Software

Eko Analysis Software (Tool A) offers a transparent freemium model with a subscription for full features, allowing users to experience basic functionalities before committing to a paid plan. DeepRhythmAI (Tool B) is described as having an 'enterprise' pricing model with unknown details, which typically implies less flexibility and transparency for individual practitioners or smaller organizations.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI (Tool B) is explicitly designed for enterprise integration, featuring an API, data export capabilities, and a target market ranging from solo practitioners to large health systems, with numerous global customers. It also mentions compliance with HIPAA, GDPR, HITECH, and SOC 2. While Eko Analysis Software (Tool A) is HIPAA compliant and has a BAA, Tool B's comprehensive integration features and broader enterprise focus make it more robust for large-scale deployments.

Innovation

DeepRhythmAI

DeepRhythmAI (Tool B) utilizes advanced AI models like Convolutional Neural Networks (CNN) and Transformer models, trained on an enormous dataset of over 250 billion annotated heartbeats, indicating significant technological innovation in its core AI engine. Eko Analysis Software (Tool A) is innovative in its integration with digital stethoscopes and mobile app for point-of-care diagnostics, but Tool B's deep learning methodology and massive training data represent a more cutting-edge approach to AI in cardiac diagnostics.

Support & Docs

Eko Analysis Software

Eko Analysis Software (Tool A) benefits from Eko Health's comprehensive and publicly accessible support resources, including a help center with FAQs, user manuals, live Q&A sessions, and direct contact options. DeepRhythmAI (Tool B), being an enterprise-focused solution without a native user interface, has less publicly available direct user support or documentation, relying more on integration partners and direct enterprise agreements.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software DeepRhythmAI
Name Eko Analysis Software DeepRhythmAI
Company Eko Devices Medicalgorithmics S.A.
Primary AI Detections Heart murmur detection, Atrial fibrillation (AFib) detection, Normal sinus rhythm detection Cardiac arrhythmia detection and classification
Device Compatibility Eko's digital stethoscopes, Bluetooth-enabled devices Device-agnostic, integrates with various ECG devices
Mobile App Available None

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and DeepRhythmAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is FDA-cleared to assist in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation (AFib), and also detects normal sinus rhythm and calculates cardiac time intervals. DeepRhythmAI is an FDA-cleared AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, recognizing a broad array of arrhythmias.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app for wireless auscultation and ECG recordings. DeepRhythmAI is device-agnostic and integrates with various ECG devices, including Holter monitors, event recorders, and outpatient telemetry systems.
Eko Analysis Software is designed for use across Cardiology, Emergency Medicine, and Internal Medicine specialties. DeepRhythmAI primarily targets Cardiology, Electrocardiography, and Arrhythmia Detection.
Eko Analysis Software analyzes simultaneous heart sounds (phonocardiograms) and ECG tracings captured by Eko's digital stethoscopes. DeepRhythmAI focuses on analyzing ECG data, including multichannel Holter, Event, and Mobile Cardiac Telemetry data, for arrhythmia detection and classification.
Eko Analysis Software assists clinicians in the early detection of cardiovascular diseases and allows for recording, playback, and secure cloud-based storage of heart sounds and ECGs. DeepRhythmAI claims to offer superior accuracy and efficiency, reducing missed diagnoses by 14x to 114x and streamlining clinical workflows by up to 65% through faster ECG reporting and analysis.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.